|
WDR43 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.794000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.28970000000417E-05 |
| Normal-vs-Stage2 |
7.156400E-02 |
| Normal-vs-Stage3 |
4.083500E-02 |
| Normal-vs-Stage4 |
2.207400E-01 |
| Stage1-vs-Stage2 |
4.961400E-01 |
| Stage1-vs-Stage3 |
1.508960E-01 |
| Stage1-vs-Stage4 |
5.399600E-02 |
| Stage2-vs-Stage3 |
7.457800E-01 |
| Stage2-vs-Stage4 |
4.631800E-01 |
| Stage3-vs-Stage4 |
5.861000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.446500E-04 |
| Normal-vs-AfricanAmerican |
3.640200E-01 |
| Normal-vs-Asian |
1.090810E-01 |
| Caucasian-vs-AfricanAmerican |
1.662610E-01 |
| Caucasian-vs-Asian |
1.050380E-01 |
| AfricanAmerican-vs-Asian |
1.633620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.005820E-02 |
| Normal-vs-Female |
5.67980000000246E-05 |
| Male-vs-Female |
2.104100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.977560E-01 |
| Normal-vs-Age(41-60Yrs) |
2.520400E-03 |
| Normal-vs-Age(61-80Yrs) |
7.004000E-04 |
| Normal-vs-Age(81-100Yrs) |
5.246800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.589200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.261400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.148000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.038200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.565000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.597200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.861900E-02 |
| Normal-vs-Grade 2 |
1.57485999999762E-05 |
| Normal-vs-Grade 3 |
3.657600E-02 |
| Normal-vs-Grade 4 |
2.223400E-01 |
| Grade 1-vs-Grade 2 |
7.466200E-01 |
| Grade 1-vs-Grade 3 |
1.677770E-01 |
| Grade 1-vs-Grade 4 |
2.472400E-01 |
| Grade 2-vs-Grade 3 |
5.942400E-03 |
| Grade 2-vs-Grade 4 |
4.292200E-02 |
| Grade 3-vs-Grade 4 |
8.467800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.96460000279464E-08 |
| Normal-vs-ccB subtype |
4.429600E-02 |
| ccA subtype-vs-ccB subtype |
5.182400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.704160E-03 |
| Normal-vs-N1 |
2.442200E-01 |
| N0-vs-N1 |
7.464200E-01 |
|
|
